Dr Michael J O'brien, MD | |
1430 Tulane Ave, Dept. Of Orthopaedics, Sl-32, Room 2070, New Orleans, LA 70112-2632 | |
(504) 988-5770 | |
(504) 988-3517 |
Full Name | Dr Michael J O'brien |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 21 Years |
Location | 1430 Tulane Ave, New Orleans, Louisiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104960657 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207XX0005X | Orthopaedic Surgery - Sports Medicine | MD203048 (Louisiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Tulane Medical Center | New orleans, LA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Administrators Of The Tulane Educational Fund | 0446163760 | 369 |
Select Physical Therapy Holdings Inc | 9537076401 | 1487 |
News Archive
Researchers from Taiwan reveal that antiviral therapy for hepatitis C virus improves kidney and cardiovascular outcomes for patients with diabetes. Results of the study published in Hepatology, a journal of the American Association for the Study of Liver Diseases, show that incidences of kidney disease, stroke, and heart attack were lower in patients treated with pegylated interferon and ribavirin compared to HCV patients not treated with antivirals or diabetic patients not infected with the virus.
Invasive lobular carcinoma (ILC) of the breast can be treated with breast conserving surgery (BCT), as is invasive ductal carcinoma (IDC), without greater future risk of radical surgical treatment or additional surgeries, according to a new study.
Changes in ground-level ozone were significantly associated with an increase in deaths in many U.S. cities, according to a nationwide study conducted by researchers at the Johns Hopkins Bloomberg School of Public Health and the Yale University School of Forestry and Environmental Studies.
Eileen White, PhD, associate director for basic science at The Cancer Institute of New Jersey and professor of molecular biology and biochemistry at Rutgers, The State University of New Jersey, and colleagues from Princeton University have been awarded a new five-year, $2.4 million dollar research grant from the National Cancer Institute.
Health policies which favour using ranibizumab for treating eye disease in older people over safety concerns for a cheaper alternative should take account of a new Cochrane Review published today.
› Verified 7 days ago
Entity Name | Administrators Of The Tulane Educational Fund |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1528014164 PECOS PAC ID: 0446163760 Enrollment ID: O20031201000636 |
News Archive
Researchers from Taiwan reveal that antiviral therapy for hepatitis C virus improves kidney and cardiovascular outcomes for patients with diabetes. Results of the study published in Hepatology, a journal of the American Association for the Study of Liver Diseases, show that incidences of kidney disease, stroke, and heart attack were lower in patients treated with pegylated interferon and ribavirin compared to HCV patients not treated with antivirals or diabetic patients not infected with the virus.
Invasive lobular carcinoma (ILC) of the breast can be treated with breast conserving surgery (BCT), as is invasive ductal carcinoma (IDC), without greater future risk of radical surgical treatment or additional surgeries, according to a new study.
Changes in ground-level ozone were significantly associated with an increase in deaths in many U.S. cities, according to a nationwide study conducted by researchers at the Johns Hopkins Bloomberg School of Public Health and the Yale University School of Forestry and Environmental Studies.
Eileen White, PhD, associate director for basic science at The Cancer Institute of New Jersey and professor of molecular biology and biochemistry at Rutgers, The State University of New Jersey, and colleagues from Princeton University have been awarded a new five-year, $2.4 million dollar research grant from the National Cancer Institute.
Health policies which favour using ranibizumab for treating eye disease in older people over safety concerns for a cheaper alternative should take account of a new Cochrane Review published today.
› Verified 7 days ago
Entity Name | Administrators Of The Tulane Educational Fund |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1245434224 PECOS PAC ID: 0446163760 Enrollment ID: O20040114000146 |
News Archive
Researchers from Taiwan reveal that antiviral therapy for hepatitis C virus improves kidney and cardiovascular outcomes for patients with diabetes. Results of the study published in Hepatology, a journal of the American Association for the Study of Liver Diseases, show that incidences of kidney disease, stroke, and heart attack were lower in patients treated with pegylated interferon and ribavirin compared to HCV patients not treated with antivirals or diabetic patients not infected with the virus.
Invasive lobular carcinoma (ILC) of the breast can be treated with breast conserving surgery (BCT), as is invasive ductal carcinoma (IDC), without greater future risk of radical surgical treatment or additional surgeries, according to a new study.
Changes in ground-level ozone were significantly associated with an increase in deaths in many U.S. cities, according to a nationwide study conducted by researchers at the Johns Hopkins Bloomberg School of Public Health and the Yale University School of Forestry and Environmental Studies.
Eileen White, PhD, associate director for basic science at The Cancer Institute of New Jersey and professor of molecular biology and biochemistry at Rutgers, The State University of New Jersey, and colleagues from Princeton University have been awarded a new five-year, $2.4 million dollar research grant from the National Cancer Institute.
Health policies which favour using ranibizumab for treating eye disease in older people over safety concerns for a cheaper alternative should take account of a new Cochrane Review published today.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Michael J O'brien, MD 1430 Tulane Ave, Dept. Of Orthopaedics, Sl-32, Room 2070, New Orleans, LA 70112-2632 Ph: (504) 988-5770 | Dr Michael J O'brien, MD 1430 Tulane Ave, Dept. Of Orthopaedics, Sl-32, Room 2070, New Orleans, LA 70112-2632 Ph: (504) 988-5770 |
News Archive
Researchers from Taiwan reveal that antiviral therapy for hepatitis C virus improves kidney and cardiovascular outcomes for patients with diabetes. Results of the study published in Hepatology, a journal of the American Association for the Study of Liver Diseases, show that incidences of kidney disease, stroke, and heart attack were lower in patients treated with pegylated interferon and ribavirin compared to HCV patients not treated with antivirals or diabetic patients not infected with the virus.
Invasive lobular carcinoma (ILC) of the breast can be treated with breast conserving surgery (BCT), as is invasive ductal carcinoma (IDC), without greater future risk of radical surgical treatment or additional surgeries, according to a new study.
Changes in ground-level ozone were significantly associated with an increase in deaths in many U.S. cities, according to a nationwide study conducted by researchers at the Johns Hopkins Bloomberg School of Public Health and the Yale University School of Forestry and Environmental Studies.
Eileen White, PhD, associate director for basic science at The Cancer Institute of New Jersey and professor of molecular biology and biochemistry at Rutgers, The State University of New Jersey, and colleagues from Princeton University have been awarded a new five-year, $2.4 million dollar research grant from the National Cancer Institute.
Health policies which favour using ranibizumab for treating eye disease in older people over safety concerns for a cheaper alternative should take account of a new Cochrane Review published today.
› Verified 7 days ago
Amit Kumar Sharma, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 200 Henry Clay Ave, Ste 4103 Children's Hospital, New Orleans, LA 70118 Phone: 504-896-9569 | |
Dr. Joseph A. Gonzales Jr., MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 Henry Clay Avenue, New Orleans, LA 70118 Phone: 504-896-9569 | |
Dr. Raoul Pedro Rodriguez, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1415 Tulane Ave, New Orleans, LA 70112 Phone: 504-988-2177 Fax: 504-988-4200 | |
Dr. Mark S Meyer, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-4000 | |
Dr. Timothy John Skalak, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 200 Henry Clay Ave, New Orleans, LA 70118 Phone: 504-899-3496 Fax: 504-896-9849 | |
Leslie Elaine Sisco, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-3970 Fax: 504-842-6784 | |
Dr. Charles R Billings, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1415 Tulane Ave, New Orleans, LA 70112 Phone: 504-988-2177 Fax: 504-988-4200 |